The Multifaceted Role of Regulatory T Cells in Breast Cancer.

IF 4.7 2区 医学 Q1 ONCOLOGY Annual Review of Cancer Biology-Series Pub Date : 2021-03-01 Epub Date: 2020-12-04 DOI:10.1146/annurev-cancerbio-042920-104912
Kevin Kos, Karin E de Visser
{"title":"The Multifaceted Role of Regulatory T Cells in Breast Cancer.","authors":"Kevin Kos,&nbsp;Karin E de Visser","doi":"10.1146/annurev-cancerbio-042920-104912","DOIUrl":null,"url":null,"abstract":"<p><p>The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (T<sub>regs</sub>), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral T<sub>regs</sub> can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that T<sub>regs</sub> occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, T<sub>regs</sub> are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into T<sub>reg</sub> biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies.</p>","PeriodicalId":54233,"journal":{"name":"Annual Review of Cancer Biology-Series","volume":"5 ","pages":"291-310"},"PeriodicalIF":4.7000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1146/annurev-cancerbio-042920-104912","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual Review of Cancer Biology-Series","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1146/annurev-cancerbio-042920-104912","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/12/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 19

Abstract

The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (Tregs), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral Tregs can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that Tregs occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, Tregs are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into Treg biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
调节性T细胞在乳腺癌中的多重作用。
乳腺癌的微环境承载着免疫系统不同参与者之间的动态串扰。虽然细胞毒性免疫细胞能够控制肿瘤的生长和转移,但肿瘤破坏的免疫抑制免疫细胞会努力损害有效免疫并促进肿瘤的进展。其中,调节T细胞(Tregs),免疫稳态的守门人,在乳腺癌中扮演着多方面的角色。有趣的是,临床观察表明,血液和肿瘤内Tregs可能具有很强的预后价值,这取决于乳腺癌亚型。因此,新出现的临床前证据表明Tregs在乳腺癌的发生和发展中起着核心作用,并为转移形成提供关键支持。在这里,Tregs不仅对免疫逃逸很重要,而且还独立于其免疫调节能力促进肿瘤进展。将Treg生物学的见解与快速发展的免疫肿瘤学领域的进展相结合,有望为设计更有效的免疫治疗策略奠定基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
14.50
自引率
1.30%
发文量
13
期刊介绍: The Annual Review of Cancer Biology offers comprehensive reviews on various topics within cancer research, covering pivotal and emerging areas in the field. As our understanding of cancer's fundamental mechanisms deepens and more findings transition into targeted clinical treatments, the journal is structured around three main themes: Cancer Cell Biology, Tumorigenesis and Cancer Progression, and Translational Cancer Science. The current volume of this journal has transitioned from gated to open access through Annual Reviews' Subscribe to Open program, ensuring all articles are published under a CC BY license.
期刊最新文献
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer Next-Generation Estrogen Receptor–Targeted Therapeutics Engineering the Immune Microenvironment into Organoid Models The Effects of Clonal Heterogeneity on Cancer Immunosurveillance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1